Tiago Fleming Outeiro

Citée par

	Toutes	Depuis 2020
Citations	40094	19059
indice h	90	61
indice i10	267	241

4200

2100

1050

3150

20062007200820092010201120122013201420152016201720182019202020212022202320242025158 205 390 501 714 924 1080 1474 1862 2049 2336 2758 2975 3161 3467 4169 3847 3437 3661 459

Accès public

Tout afficher

251 articles

34 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Diana F. LázaroCenter for Neurodegenerative Disease Research, UPennAdresse e-mail validée de pennmedicine.upenn.edu
Sandra TenreiroNova Medical School- Universidade NOVA de Lisboa, Lisbon, PortugalAdresse e-mail validée de nms.unl.pt
Markus ZweckstetterGerman Center for Neurodegenerative Diseases (DZNE)Adresse e-mail validée de dzne.de
Hugo Vicente MirandaNOVA Medical School (NMS), New University of Lisbon (UNL)Adresse e-mail validée de nms.unl.pt
Flaviano GiorginiProfessor of Neurogenetics, University of LeicesterAdresse e-mail validée de le.ac.uk
Bradley HymanMassachusetts General Hospital, Harvard Medical SchoolAdresse e-mail validée de partners.org
Pamela McLeanMayo ClinicAdresse e-mail validée de mayo.edu
Eva M. SzegoDept. Neurology, Technische Universität DresdenAdresse e-mail validée de ukdd.de
Johannes AttemsNewcastle UniveristyAdresse e-mail validée de ncl.ac.uk
Joaquim FerreiraFaculdade de Medicina, Universidade de LisboaAdresse e-mail validée de medicina.ulisboa.pt
Luísa V. LopesPrincipal Investigator, iMM, Faculdade de Medicina, Universidade de LisboaAdresse e-mail validée de medicina.ulisboa.pt
Tomás Lopes da FonsecaBayer AGAdresse e-mail validée de allmaclong.com
Federico HerreraFaculty of Sciences, University of Lisbon, Lisbon, PortugalAdresse e-mail validée de fc.ul.pt
Jochen KluckenUniversity of Luxembourg, Centre Hospitalier du LuxembourgAdresse e-mail validée de uni.lu
Omar El-AgnafQatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar FoundationAdresse e-mail validée de hbku.edu.qa
Braus, GerhardProfessor for Microbiology and Genetics, University of GoettingenAdresse e-mail validée de gwdg.de
Joana Esteves CoelhoiMMLisboaAdresse e-mail validée de medicina.ulisboa.pt
Luc BueeUniversité de LilleAdresse e-mail validée de univ-lille.fr
Paul MuchowskiUCSFAdresse e-mail validée de gladstone.ucsf.edu
Claudia Nunes dos SantosNOVA Medical School, Universidade Nova de LisboaAdresse e-mail validée de nms.unl.pt

Suivre

Tiago Fleming Outeiro

University Medical Center Goettingen, Goettingen, Germany

Adresse e-mail validée de gwdg.de - Page d'accueil

Neurodegeneration Parkinson's disease Huntington's disease amyloid protein misfolding


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹ DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021	13832*	2021
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease TF Outeiro, E Kontopoulos, SM Altmann, I Kufareva, KE Strathearn, ... science 317 (5837), 516-519, 2007	1299	2007
Yeast cells provide insight into alpha-synuclein biology and pathobiology TF Outeiro, S Lindquist Science 302 (5651), 1772-1775, 2003	1039	2003
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells C Hansen, E Angot, AL Bergström, JA Steiner, L Pieri, G Paul, TF Outeiro, ... The Journal of clinical investigation 121 (2), 715-725, 2011	989	2011
Formation of toxic oligomeric α-synuclein species in living cells TF Outeiro, P Putcha, JE Tetzlaff, R Spoelgen, M Koker, F Carvalho, ... PloS one 3 (4), e1867, 2008	539	2008
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein S Willingham, TF Outeiro, MJ DeVit, SL Lindquist, PJ Muchowski Science 302 (5651), 1769-1772, 2003	539	2003
SIRT1 and SIRT2: emerging targets in neurodegeneration G Donmez, TF Outeiro EMBO molecular medicine 5 (3), 344-352, 2013	465	2013
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ... Experimental neurology 213 (2), 315-325, 2008	460	2008
Dementia with Lewy bodies: an update and outlook TF Outeiro, DJ Koss, D Erskine, L Walker, M Kurzawa-Akanbi, D Burn, ... Molecular neurodegeneration 14, 1-18, 2019	401	2019
Alpha-synuclein: from secretion to dysfunction and death O Marques, TF Outeiro Cell death & disease 3 (7), e350-e350, 2012	396	2012
Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington’s and Parkinson’s diseases RA Bodner, TF Outeiro, S Altmann, MM Maxwell, SH Cho, BT Hyman, ... Proceedings of the National Academy of Sciences 103 (11), 4246-4251, 2006	350	2006
Protein phosphorylation in neurodegeneration: friend or foe? S Tenreiro, K Eckermann, TF Outeiro Frontiers in molecular neuroscience 7, 42, 2014	309	2014
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation MJ Diógenes, RB Dias, DM Rombo, HV Miranda, F Maiolino, P Guerreiro, ... Journal of Neuroscience 32 (34), 11750-11762, 2012	309	2012
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease M Martins, A Rosa, LC Guedes, BV Fonseca, K Gotovac, S Violante, ... PloS one 6 (10), e25443, 2011	308	2011
Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies A Villar‐Piqué, T Lopes da Fonseca, TF Outeiro Journal of neurochemistry 139, 240-255, 2016	301	2016
α-synuclein interacts with PrP^C to induce cognitive impairment through mGluR5 and NMDAR2B DG Ferreira, M Temido-Ferreira, H Vicente Miranda, VL Batalha, ... Nature neuroscience 20 (11), 1569-1579, 2017	297	2017
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super‐resolution microscopy KN Richter, NH Revelo, KJ Seitz, MS Helm, D Sarkar, RS Saleeb, E d'Este, ... The EMBO journal 37 (1), 139-159, 2018	288	2018
Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro IL Derkatch, SM Uptain, TF Outeiro, R Krishnan, SL Lindquist, ... Proceedings of the National Academy of Sciences 101 (35), 12934-12939, 2004	263	2004
Emerging role of sirtuin 2 in the regulation of mammalian metabolism P Gomes, TF Outeiro, C Cavadas Trends in pharmacological sciences 36 (11), 756-768, 2015	259	2015
Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation DF Lázaro, EF Rodrigues, R Langohr, H Shahpasandzadeh, T Ribeiro, ... PLoS genetics 10 (11), e1004741, 2014	252	2014

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs